These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 32589942)
1. Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer. Tang Y; Fang G; Guo F; Zhang H; Chen X; An L; Chen M; Zhou L; Wang W; Ye T; Zhou L; Nie P; Yu H; Lin M; Zhao Y; Lin X; Yuan Z; Jiao S; Zhou Z Cancer Cell; 2020 Jul; 38(1):115-128.e9. PubMed ID: 32589942 [TBL] [Abstract][Full Text] [Related]
2. Reactivating Hippo by drug compounds to suppress gastric cancer and enhance chemotherapy sensitivity. Cao Z; Hou Y; Zhao Z; Zhang H; Tian L; Zhang Y; Dong C; Guo F; Tan L; Han Y; Wang W; Jiao S; Tang Y; An L; Zhou Z J Biol Chem; 2024 Jun; 300(6):107311. PubMed ID: 38657866 [TBL] [Abstract][Full Text] [Related]
3. Cryo-EM structure of the Hippo signaling integrator human STRIPAK. Jeong BC; Bae SJ; Ni L; Zhang X; Bai XC; Luo X Nat Struct Mol Biol; 2021 Mar; 28(3):290-299. PubMed ID: 33633399 [TBL] [Abstract][Full Text] [Related]
4. Good Guy in Bad Company: How STRNs Convert PP2A into an Oncoprotein. Kurppa KJ; Westermarck J Cancer Cell; 2020 Jul; 38(1):20-22. PubMed ID: 32663465 [TBL] [Abstract][Full Text] [Related]
5. Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer. Kim SH; Jin H; Meng RY; Kim DY; Liu YC; Chai OH; Park BH; Kim SM Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547587 [TBL] [Abstract][Full Text] [Related]
6. Cooperation of Striatin 3 and MAP4K4 promotes growth and tissue invasion. Migliavacca J; Züllig B; Capdeville C; Grotzer MA; Baumgartner M Commun Biol; 2022 Aug; 5(1):795. PubMed ID: 35941177 [TBL] [Abstract][Full Text] [Related]
7. STRN3 promotes tumour growth in hepatocellular carcinoma by inhibiting the hippo pathway. Zhu J; Tang W; Fang P; Wang C; Gu M; Yang W; Pan B; Wang B; Guo W J Cell Mol Med; 2024 Mar; 28(6):e18147. PubMed ID: 38429901 [TBL] [Abstract][Full Text] [Related]
8. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway. Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198 [TBL] [Abstract][Full Text] [Related]
9. MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway. An L; Nie P; Chen M; Tang Y; Zhang H; Guan J; Cao Z; Hou C; Wang W; Zhao Y; Xu H; Jiao S; Zhou Z J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32271880 [TBL] [Abstract][Full Text] [Related]
10. The Human Adenovirus Type 5 E4orf4 Protein Targets Two Phosphatase Regulators of the Hippo Signaling Pathway. Mui MZ; Zhou Y; Blanchette P; Chughtai N; Knight JF; Gruosso T; Papadakis AI; Huang S; Park M; Gingras AC; Branton PE J Virol; 2015 Sep; 89(17):8855-70. PubMed ID: 26085163 [TBL] [Abstract][Full Text] [Related]
11. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells. Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291 [TBL] [Abstract][Full Text] [Related]
12. 3,3'-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway. Li XJ; Park ES; Park MH; Kim SM Oncol Rep; 2013 Nov; 30(5):2419-26. PubMed ID: 24008339 [TBL] [Abstract][Full Text] [Related]
13. Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway. Suh JH; Won KY; Kim GY; Bae GE; Lim SJ; Sung JY; Park YK; Kim YW; Lee J Int J Clin Exp Pathol; 2015; 8(11):14608-18. PubMed ID: 26823784 [TBL] [Abstract][Full Text] [Related]
14. Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway. Li Z; Razavi P; Li Q; Toy W; Liu B; Ping C; Hsieh W; Sanchez-Vega F; Brown DN; Da Cruz Paula AF; Morris L; Selenica P; Eichenberger E; Shen R; Schultz N; Rosen N; Scaltriti M; Brogi E; Baselga J; Reis-Filho JS; Chandarlapaty S Cancer Cell; 2018 Dec; 34(6):893-905.e8. PubMed ID: 30537512 [TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor RASSF1A prevents dephosphorylation of the mammalian STE20-like kinases MST1 and MST2. Guo C; Zhang X; Pfeifer GP J Biol Chem; 2011 Feb; 286(8):6253-61. PubMed ID: 21199877 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer. Wang T; Wang D; Sun Y; Zhuang T; Li X; Yang H; Zang Y; Liu Z; Yang P; Zhang C; Cui J; Fu M; Zhang S; Su P; Li Z; Zhu J; Ding Y J Exp Clin Cancer Res; 2023 Nov; 42(1):297. PubMed ID: 37950281 [TBL] [Abstract][Full Text] [Related]
17. STRIPAK components determine mode of cancer cell migration and metastasis. Madsen CD; Hooper S; Tozluoglu M; Bruckbauer A; Fletcher G; Erler JT; Bates PA; Thompson B; Sahai E Nat Cell Biol; 2015 Jan; 17(1):68-80. PubMed ID: 25531779 [TBL] [Abstract][Full Text] [Related]
18. T851I mutation of human large tumor suppressor 1 disrupts its kinase activity and tumor-suppressor functions. Zhang Q; Du X; He Q; Shi W; Mei L; Qv M; Tan D; Wu J; Zeng LH; Wu X Life Sci; 2021 Jan; 264():118655. PubMed ID: 33141042 [TBL] [Abstract][Full Text] [Related]
19. Striatins contain a noncanonical coiled coil that binds protein phosphatase 2A A subunit to form a 2:2 heterotetrameric core of striatin-interacting phosphatase and kinase (STRIPAK) complex. Chen C; Shi Z; Zhang W; Chen M; He F; Zhang Z; Wang Y; Feng M; Wang W; Zhao Y; Brown JH; Jiao S; Zhou Z J Biol Chem; 2014 Apr; 289(14):9651-61. PubMed ID: 24550388 [TBL] [Abstract][Full Text] [Related]
20. Neddylation mediates ventricular chamber maturation through repression of Hippo signaling. Zou J; Ma W; Li J; Littlejohn R; Zhou H; Kim IM; Fulton DJR; Chen W; Weintraub NL; Zhou J; Su H Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E4101-E4110. PubMed ID: 29632206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]